Cancer cells frequently develop the ability to expel anticancer drugs before they can work—a phenomenon called multidrug resistance (MDR)—which is one of the leading reasons why chemotherapy fails in ...

A new study led by NYU Langone Health researchers has found that cancer cells are better able to resist treatments when they ...

Creativity and curiosity have always been central to the work of Joshua Moreau, Ph.D., an immunologist whose work at Oregon ...

Researchers from Utah State University, University of Utah Health, the Helmholtz Institute for RNA-based Infection Research ...

A new kind of CRISPR that destroys cells rather than gene editing them has shown potential for killing sick cells while leaving healthy cells untouched. The technology has largely been tested in cells ...

Sam Neill had been undergoing chemotherapy for years, but the treatment eventually became ineffective. At one point, he ...

Cancer immunotherapy is built on a simple but powerful idea: the immune system can recognize and destroy cancer cells if it is properly activated. In many patients, however, this response is too weak ...

The data published in NEJM reflect outcomes in the PDAC cohort from the RMC-6236-001 trial (NCT05379985), an open-label, multicenter Phase 1/2 trial evaluating daraxonrasib monotherapy in patients ...

Among the challenges in treating disease, including cancer, is wiping out malignancies, infection, contaminants or other ...

Below are summaries of recent Fred Hutch Cancer Center research findings, patient stories and other news. May is the awareness month for skin and bladder cancers, melanoma and mental health. To ...

According to a new study published in the journal Science, the mechanical load from the constant beating of the heart might be aiding in consistently suppressin ...

A new study performed on breast cancer patients who are undergoing chemotherapy shows positive health outcomes when they ...